Citations

Clear

6052 citation(s) found for "Vu, Peter".

Adopting Race‐Free Estimated Glomerular Filtration Rate for Unifying Medication‐Related Decision‐Making: An Opinion of the Nephrology Practice and Research Network of the American College of Clinical Pharmacy
Wallace, J. , Rungkitwattanakul, Dhakrit , Khan, Rachel W. , Anderson, Lauren , Anderson, Erica , Nekidy, Wasim S. El , Nemecek, Branden D. , Meaney, Calvin J. , Prasad‐Reddy, Lalita , Salama, Lavinia , Hudson, Joanna Q. , Kane‐Gill, Sandra L. , Frazee, Erin N. , Anderson, Erica R , El Nekidy, Wasim S , Frazee, Erin N , Bzowyckyj, Andrew S , Kane-Gill, Sandra L , Peter, Wendy L. St.

Mayo Clinic

JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY | November 27, 2025 | Volume: 9 | Issue: 2 | Pages: No page available

10.1002/jac5.70153 | PMID 42009503 Get It

ABSTRACT Pharmacists play a critical role in optimizing medication use, especially in vulnerable populations such as those with chronic kidney disease (CKD). Despite strong evidence and recent guideline endorsements, many pharmacists continue to rely on the Cockcroft–Gault (C‐G) equation for medication dosing. This opinion paper issues a call to action for the widespread adoption of a race‐free, body surface area–adjusted estimated glomerular filtration rate (eGFR BSAadj ) for medication‐related decision‐making, as endorsed by the 2024 Kidney Disease: Improving Global Outcomes CKD guidelines and the National Kidney Foundation and the American Society of Nephrology Taskforce. Persistent variability in pharmacy practice, institutional protocols, and pharmacy education underscores the need for coordinated change. We urge health systems to integrate eGFR BSAadj into electronic health records and clinical decision support to enhance medication decision‐making; institutions to align protocols with contemporary eGFR‐based prescribing standards; pharmacy educators to contemporize and standardize education on kidney function assessment and medication dosing; and regulatory bodies to update licensure and board examinations. The pharmacy profession must act decisively in order to align with evidence‐based, equitable kidney‐related dosing practices and ensure optimal medication management for all patients.
Efficacy of Mirikizumab in Comparison to Ustekinumab in Patients With Moderate-to-Severe Crohn’s Disease: Results From the Phase 3 VIVID-1 Study
Ferrante, M., Kaser, Arthur , Reinisch, Walter, Bragg, S. M., Lin, Zhantao, Lopes, Michelle Ugolini, Protić, Marijana , Jairath, Vipul , Sands, Bruce E , Bossuyt, Peter , Farraye, Francis A. , Hisamatsu, T., Kierkuś, Jarosław , Laharie, David , Siegmund, Britta , Hon, Kam‐Lun Ellis , Morris, Nathan , Danese, Silvio

Mayo Clinic

Zeitschrift für Gastroenterologie | November 27, 2025 | Volume: 62 | Issue: 05 | Pages: e481-e482

10.1055/s-0044-1786891 Get It

Phase-1 Cardiac Rehabilitation in Acute Heart Failure: Development of an Early Mobilization Algorithm Through Delphi Consensus
Satyamurthy, Akhila , Padmakumar, Ramachandran, Harikrishnan, Sivadasanpillai , Contractor, Aashish , Ozemek, Cemal , Bryant, Eryn, Ghisi, Gabriela Lima de Melo, Myers, Jonathan A. , Madan, Kushal , Supervía, Marta , Morris, Norman , Brubaker, Peter H. , Roos, Ronel , Hiser, Stephanie , Shanbhag, Vishal , Babu, Abraham Samuel , Babu, Abraham Samuel , Ramachandran, Padmakumar , Prabhu, Mukund Aravind , Jeemon, Panniyammakal , Ghisi, Gabriela Lima de Melo, Paramasivam, Ganesh , Myers, Jonathan, Hanekom, Susan D. , Yeo, Tee Joo

Mayo Clinic

Journal of Cardiopulmonary Rehabilitation and Prevention | November 26, 2025 | Volume: 46 | Issue: 1 | Pages: 58-66

10.1097/hcr.0000000000000978 | PMID 41294777 Get It

Purpose: Literature on early mobilization and exercise training in patients recovering from acute heart failure (AHF) is promising. However, there lacks uniformity in the time of initiation, exercise prescription, safety criteria, and termination criteria. Thus, the aim was to develop a mobilization algorithm for patients recovering from AHF. Methods: A modified web-based Delphi process was undertaken involving 15 panelists from across the globe. In Round 1, new variables, modifications to suggested variables, and agreement-disagreement within the panelists were obtained. In Round 2, agreement on a 5-point Likert scale was obtained. In Round 3, the algorithm was compiled, and excluded statements were discussed via web-based calls. The new variables were grouped into themes via an inductive process. The level of agreement and rating for each statement were analyzed using descriptive statistics, including frequency and percentages. We used Kappa statistics to examine the level of agreement between the panelists for each criterion. The consensus criterion was defined a priori as statements with a mean rating of ≥4 on the 5-point Likert scale by ≥70% of the panelists and Kendall’s coefficient of concordance ( W ) of ≥0.3 between panelists. Results: From Round 1, 54 new variables were obtained. More than two-thirds (118/170, 69%) of statements reached consensus and reported a fair level of agreement between panelists ( W ≥ 0.3). The final algorithm with all its criteria received a 100% (13/13) consensus. Conclusion: Physician-referral criteria, physiotherapy assessment process, exercise prescription, safety criteria, and termination criteria were formulated for early mobilization and exercise training for patients recovering from AHF.
Association of Radiomics and Pericarotid Adipose Tissue Characteristics with Systemic Inflammation in Patients Undergoing Carotid Endarterectomy
Santos-Teixeira, Diogo, Myrcha, Piotr , Trigo, Vasco, Barbosa‐Breda, João , Rocha‐Neves, João , Barbosa-Breda, João , Rocha-Neves, João , Ribeiro, Hugo C. , Dias‐Neto, Marina , Gloviczki, Péter

Mayo Clinic

Journal of Clinical Medicine | November 25, 2025 | Volume: 14 | Issue: 23 | Pages: 8342

10.3390/jcm14238342 | PMID 41375644 Get It

Background: Pericarotid adipose tissue (PCAT) characteristics and systemic inflammation may play an important role in carotid endarterectomy (CEA) outcomes. This study explores the association between PCAT Hounsfield Unit (HU) ranges, radiomic features, and systemic inflammatory markers in patients undergoing carotid endarterectomy (CEA). Methods: Twenty patients undergoing CEA were included in this cross-sectional study. PCAT was analyzed using preoperative computed tomography angiography (CTA) images, with regions of interest defined around the carotid arteries. PCAT was categorized into three HU ranges: −190 to −120, −119 to −70, and −69 to −30. Radiomics features were extracted using PyRadiomics. The primary outcome was the correlation of PCAT imaging with preoperative neutrophil-to-lymphocyte ratios (NLRs). The secondary outcome was the association of PCAT imaging with the red cell distribution width (RDW-CV). Linear regression was used to evaluate associations between PCAT characteristics and inflammatory markers. Results: Distinct HU ranges in PCAT imaging showed strong correlations with the preoperative NLR. The −190 to −120 HU range demonstrated a negative association (β = −3.809, p < 0.001), whereas the −119 to −70 HU range showed a positive correlation (β = 3.814, p < 0.001). PCAT uniformity was positively associated with RDW-CV (β = 0.494, p = 0.027). Other radiomics features, such as contrast, showed trends but did not reach statistical significance. A larger outer area of PCAT was inversely associated with the NLR (β = −0.677, p < 0.001). Conclusions: Specific PCAT HU ranges and radiomics features are significantly associated with systemic inflammatory markers in CEA patients. These findings suggest that HU-based segmentation and radiomics analysis of PCAT may offer valuable insights into the relationship between local adipose tissue characteristics and systemic inflammation.
A Ciliary Phosphoinositide Pathway Regulates the Dosage of Polycystins in Primary Cilia
Wang, Zhifei , Ellis, Madilyn R. , Ji, Biyun , Sieben, Cynthia J. , Haycraft, Courtney J. , Croyle, Mandy J. , Aghevli, Ariana, Xu, Qingwen , Robichaud, Jielu Hao, Huang, Yan , Yoder, Bradley K. , Hu, Jinghua , Yu, Yong , Ling, Kun , Chen, Chuan , Wang, Zhifei , Gao, Yue, Ellis, Madilyn R , Ji, Biyun , Sieben, Cynthia J , Croyle, Mandy , Xu, Qingwen , Robichaud, Jielu H, He, Kai , Huang, Yan , Yoder, Bradley K , Harris, Peter C , Yu, Yong , Ling, Kun , Chen, Chuan , Gao, Yue , Hao, Jielu , He, Kai , Chen, Chunhua , Harris, Peter C.

Mayo Clinic

Journal of the American Society of Nephrology | November 25, 2025 | Volume: 37 | Issue: 5 | Pages: 944-958

10.1681/asn.0000000942 | PMID 41563398 Get It

Key Points Inositol polyphosphate-5-phosphatase E (INPP5E) and type Ig phosphatidylinositol-4-phosphate 5-kinase (PIPKIγ) coordinated the homeostasis of phosphatidylinositol-4-phosphate and phosphatidylinositol-4,5-bisphosphate in primary cilia. Modulating INPP5E or PIPKIγ activity changed the level of polycystin-1 and polycystin-2 in primary cilia. INPP5E inhibition increased the hypomorphic PKD1 variants (PC1-R3277C) in cilia and reduced cystogenesis in the kidney in vitro . Background Autosomal dominant polycystic kidney disease is mainly caused by mutations in PKD1 and PKD2 , which encode polycystin-1 (PC1) and polycystin-2 (PC2), respectively. PC1 and PC2 assemble a cation channel complex enriched in primary cilium, a sensory organelle associated with various developmental diseases, including polycystic kidney disease (PKD). Accumulating evidence supports the necessity of functional polycystin (PC) complex in cilia to prevent cystogenesis in the kidney, indicating that improving their ciliary levels may ameliorate defects underlying PKD pathogenesis. Yet, molecular mechanisms underlying the ciliary targeting and homeostasis of the PC complex are not fully understood. Methods Indirect immunofluorescence microscopy was used to monitor ciliary levels of PC1 and PC2 in renal epithelial cells. Electrophysiology analysis in oocytes was used to determine the channel activity of the PC complex. Cystogenesis in the kidney was measured using in vitro 3D-Matrigel cell models and ex vivo mouse embryonic kidney models. Results Suppressing inositol polyphosphate-5-phosphatase E (INPP5E) or activating type Ig phosphatidylinositol-4-phosphate 5-kinase raised ciliary levels of the PC complex in both normal renal epithelial cells and cells carrying autosomal dominant polycystic kidney disease mutations that interrupt the trafficking of PCs into cilia, including GANAB inactivation and the trafficking PKD1 mutation p.Arg3277Cys (RC). PC1 RC formed a complex with PC2 and exhibited normal channel activity in vitro . An INPP5E that increases PC1 and PC2 in cilia, suppressed in vitro forskolin-induced cystogenesis of inner medullary collecting duct epithelial cell line 3 cells in 3D Matrigel and ex vivo cyst formation in embryonic Pkd1 RC/RC mouse kidneys. Conclusions Our results demonstrated that increasing the ciliary level of PCs, by manipulating a ciliary phosphoinositide signaling axis, enhanced the functionality of PCs and suppressed cystogenesis of renal epithelial cells in vitro .
Verschluss perianaler Fisteln bei Patient:innen unter Ustekinumab: Ergebnisse der Studien SEAVUE und STARDUST
Kuehbacher, T, Peyrin-Biroulet, L, Gasink, Christopher , Hoops, Timothy, Izanec, James , Nazar, M, Bravatà, Ivana, Lahaye, Marjolein, Sands, BE, Kuehbacher, Tanja, Peyrin‐Biroulet, Laurent , Panaccione, Remo , Ma, T, Irving, Peter Miles , Loftus, Edward V. , Danese, Silvio

Mayo Clinic

Zeitschrift für Gastroenterologie | November 25, 2025 | Volume: 60 | Issue: 08 | Pages: e425-e426

10.1055/s-0042-1754603 Get It

Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial
Cliff, Edward R. Scheffer , Simon, Florian , Hilal, Talal , Seymour, John F. , Lew, Thomas E, Simon, Florian , Hilal, Talal , Anderson, Mary Ann, Thompson, Philip A , Seymour, John F , Lew, Thomas Eliot , Anderson, Mary Ann

Mayo Clinic

Journal of Clinical Oncology | November 21, 2025 | Volume: 44 | Issue: 3 | Pages: 254-256

10.1200/jco-25-01695 | PMID 41270246 Get It

Antigen-specific CD8 T cells are generated and reactivated in the bone marrow following viral infection in the brain 3268
Moelker, Eliese , Reesman, Rachael , Anani‐Wolf, Delaney, Tritz, Zachariah Peter , Fain, Cori E. , Johnson, Aaron J. , Tritz, Zachariah P. , Pfaller, Christian K. , Hoyt-Miggelbrink, Alexandra M. , Johnson, Aaron J. , Ayasoufi, Katayoun

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.1086 Get It

Abstract Description Bone marrow (BM) is the primary immune organ responsible for stem cell maintenance. Neurotropic infections elicit sequestration of T cells within the BM. Changes of the BM niche during brain viral infections are unknown. Intracranial infection with the neurotropic Theiler’s Murine Encephalomyelitis Virus (TMEV) in C57BL/6 mouse is cleared by 30 days due to generation of an antigen-specific CD8 T cell response. We determined that 1-10% of CD8 T cells present in the sternal, femoral, and cranial BM were virus antigen-specific 7 days post intracranial infection. Over 70% of these CD8 T cells were tissue resident. We determined antigen-specific CD8 T cells were generated in the BM within 4 days of infection, a timeline similar to lymph nodes. Continuous treatment with FTY720, which sequesters T cells outside of the blood, did not eliminate antigen-specific CD8 T cells in any BM compartment. CD8 T cells in the BM established durable memory populations and were reactivated upon antigen reencounter. Both acute infection and reactivation caused an increase in lineage-, Sca-1+, ckit + (LSK) cells in the BM. This LSK dysregulation was abrogated upon CD8 T cell depletion and was limited to the intracranial routes of infection. We conclude that brain viral infections induce in situ effector and memory T cell responses within the BM and cause stem cell dysregulation. Our data paves the way for crucial studies of BM resident antigen-specific CD8 T cells in health and disease. Topic Categories Viral Immunology (VIR)
Deficiency of Hv1 Proton Channel Enhances Macrophage Antigen Presentation and Anti-Tumor Responses in Glioma 4365
Zheng, Jiaying, Wang, Lingxiao , Wan, Yushan , Johnson, Aaron J. , Wu, Long‐Jun , Wu, Long-Jun , Zhao, Shunyi , Ayasoufi, Katayoun , Goddery, Emma N. , Strege, Peter R. , Zhang, Wenjing, Xie, Manling , Beyder, Arthur , Johnson, Aaron J.

Mayo Clinic

The Journal of Immunology | November 21, 2025 | Volume: 214 | Issue: Supplement_1 | Pages: No page available

10.1093/jimmun/vkaf283.2059 Get It

Abstract Description In the tumor microenvironment of glioblastoma, myeloid cells act as a double-edged sword—they are a major cellular component suppressing the immune response while serving as a promising therapeutic target. Our study sheds light on the voltage-gated proton channel Hv1, predominantly expressed in myeloid cells, as a pivotal regulator of their physiological functions. Elevated Hv1 expression correlates strongly with poor prognosis in glioblastoma patients, underscoring its clinical significance. Using a glioma mouse model, we demonstrated that Hv1 depletion markedly extended survival. To overcome the limitations of existing tools, we engineered novel transgenic mouse lines optimized for Hv1 research. Our findings revealed tumor-induced Hv1 upregulation, with glioma-associated macrophages identified as the principal contributors. Crucially, we identified that Hv1 in infiltrating macrophages as the major driver of survival phenotype differences. Through a multi-faceted approach combining in vivo two-photon imaging, spectral flow cytometry, and spatial transcriptomic sequencing, we discovered that Hv1 depletion limits macrophage infiltration and enhances antigen presentation, ultimately fostering a stronger adaptive immune response. These findings establish the Hv1 channel as a crucial new immune regulator within the brain tumor milieu, offering a promising target for reprogramming macrophage function to combat glioblastoma. Funding Sources Supported by NIH R35NS132326 (LJW); Mayo Clinic Cancer Center and Mayo Clinic Center for Biomedical Discovery. Topic Categories Neuroimmunology (NEUR)
Peter James Dyck: In Memoriam
Dyck, Peter James , Litchy, William J.

Mayo Clinic

Journal of the Peripheral Nervous System | November 20, 2025 | Volume: 30 | Issue: 4 | Pages: No page available

10.1111/jns.70073 Get It